It has been a mixed year for Chemomab Therapeutics Ltd. insiders: $20,000 bought by one person and $6,516 sold by one, so more buying than selling overall.
Mor George Adi (CEO) made the biggest buy, worth around $10,000. Notably, at least one C-suite executive was among the buyers.
Big money check: 13 institutions held CMMB as of Q2 2026, and more funds sold than bought. Zooming out by quarter: Last full quarter: net selling by insiders. Insiders bought in 1 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | Cohen Neil Harris | Director | Sell | 1,304 | $2.85 | $4K | SEC |
| Sep 1, 2026 | Cohen Neil Harris | Director | Sell | 1,000 | $2.80 | $3K | SEC |
| Jun 1, 2026 | Mor George Adi | CEO | Buy | 4,878 | $2.05 | $10K | SEC |
| Jun 1, 2026 | Mor George Adi | CEO | Buy | 4,926 | $2.08 | $10K | SEC |
| Jan 5, 2023 | OrbiMed Israel BioFund GP Limited Partnership | 10% Owner | Sell | 70,524 | $4.51 | $318K | SEC |
| Jan 5, 2023 | OrbiMed Israel BioFund GP Limited Partnership | 10% Owner | Sell | 266,376 | $3.34 | $890K | SEC |
| Jan 5, 2023 | Mor George Adi | Executive Officer | Sell | 6,100 | $5.03 | $31K | SEC |
| Jan 5, 2023 | Mor George Adi | Executive Officer | Sell | 7,700 | $5.03 | $39K | SEC |
In the last 12 months Chemomab Therapeutics Ltd. insiders made open-market purchases worth about $20,000 and sales worth about $6,516. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in CMMB was filed on 2026-09-01.
13 investment managers reported holding CMMB in SEC Form 13F filings for Q2 2026.
No congressional trades in CMMB were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).